Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
76.69
-0.63 (-0.81%)
Official Closing Price
Updated: 7:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
66
67
Next >
What the Options Market Tells Us About CVS Health
↗
February 05, 2024
Via
Benzinga
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
↗
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
CVS Health Unusual Options Activity For February 02
↗
February 02, 2024
Via
Benzinga
Wall Street Favorites: 3 Undervalued Stocks With Strong Buy Ratings for January 2024
↗
January 30, 2024
Although it may be tempting to ride the coattails of the usual suspects, investors should consider undervalued stocks January 2024.
Via
InvestorPlace
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
↗
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Check Out What Whales Are Doing With CVS
↗
January 18, 2024
Via
Benzinga
Peering Into CVS Health's Recent Short Interest
↗
January 17, 2024
Via
Benzinga
Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?
↗
January 30, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
January 30, 2024
Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance
Via
MarketBeat
Wall Street HATES These Three Stocks
↗
January 29, 2024
Professional investors on Wall Street are betting against a handful of consumer stocks.
Via
Talk Markets
Fortune 100 Giant Tyson Foods Breaks Ties With CVS Caremark, Marks Shift Towards Transparent Pharmacy Benefit Managers
↗
January 25, 2024
Tyson Foods shifts from CVS Caremark to startup Rightway, targeting a 15% reduction in pharmacy costs. Explore Tyson's move and its impact on the pharmacy benefits landscape.
Via
Benzinga
P/E Ratio Insights for CVS Health
↗
January 15, 2024
Via
Benzinga
Humana Blames Medicare Advantage As Stock Falls After Larger Than Expected Quarterly Loss, Grim Outlook
↗
January 25, 2024
Humana faces challenges as Q4 2023 earnings disappoint. Adjusted EPS loss at $(0.11), revenue at $25.73 billion.
Via
Benzinga
Humana Dives On Huge 2024 Earnings Warning
↗
January 25, 2024
The health insurer says earnings will be barely half of estimates.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 23, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
January 22, 2024
Via
Benzinga
MarketBeat Week in Review – 1/15 - 1/19
January 20, 2024
The market continues to bounce back and forth as investors wait on news from the Federal Reserve later this month, but inflation may still be the bigger story
Via
MarketBeat
Topics
Economy
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
↗
January 18, 2024
The "buy everything" sentiment that powered equity indices higher last quarter is over. It's a stock picker's market, Marc Chaikin says.
Via
Benzinga
Medicare Patients Alert! Biden Administration Finalizes Rule to Streamline Health Insurance Prior Authorization
↗
January 18, 2024
Biden Administration's rule for health information exchange and prior authorization processes in government-backed insurance plans. Streamlined procedures, reduced wait times, and estimated $15 billion...
Via
Benzinga
Humana Stock Falls Ill On This Warning; UNH, CVS Catch Virus
↗
January 18, 2024
Humana slashed its Q4 earnings outlook on higher medical costs and warned about weak Medicare Advantage enrollment.
Via
Investor's Business Daily
Healthcare Insurance Giant Humana Stock Hits 52-Week Low Today - Here's Why
↗
January 18, 2024
Humana revises fiscal 2023 earnings outlook, citing higher-than-expected healthcare costs. 2023 adjusted earnings now at $26.09/share, down from earlier forecast of $28.25/share.
Via
Benzinga
Are CVS store closures prescription for better financial health?
January 17, 2024
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.
Via
MarketBeat
Topics
Economy
If You Can Only Buy One Blue-Chip Stock in January, It Better Be One of These 7 Names
↗
January 15, 2024
If you’re looking for reliability, smart investors can’t go wrong with most of the blue-chip stocks, with dividends to boot.
Via
InvestorPlace
3 Stocks to Profit from the Telehealth Transformation
↗
January 12, 2024
Telehealth stocks capture healthcare and medicine's future but don't bet the bank on a company that can't cut it.
Via
InvestorPlace
CVS Health Adapts to Market Shifts With Pharmacy Shutdowns Within Target Stores
↗
January 12, 2024
CVS Health's strategic pharmacy changes within Target stores. Closures from Feb to Apr due to market dynamics. Prescription transfers to nearby CVS locations.
Via
Benzinga
Can My Portfolio’s 3 Worst Stocks From 2023 Rebound in 2024?
↗
January 11, 2024
The least shall be first. I'm hoping for these underperforming companies to become rebounding stocks this year.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 10, 2024
Via
Benzinga
3 Stocks to Capitalize on the Telehealth Explosion
↗
January 08, 2024
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 08, 2024
Via
Benzinga
24 Top Dividend Stocks to Buy and Hold in 2024
↗
January 07, 2024
These stocks could deliver positive gains in the new year -- but the real money-making opportunities are over the next decade and beyond.
Via
The Motley Fool
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
66
67
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today